Detalhe da pesquisa
1.
Phase II Study of Propylene Glycol-Free Melphalan Combined with Carmustine, Etoposide, and Cytarabine for Myeloablative Conditioning in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 22(12): 2155-2158, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27575541
2.
Structure-based parallel medicinal chemistry approach to improve metabolic stability of benzopyran COX-2 inhibitors.
Bioorg Med Chem Lett
; 21(3): 993-6, 2011 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21215625
3.
A phase I trial evaluating the effects of plerixafor, G-CSF, and azacitidine for the treatment of myelodysplastic syndromes.
Leuk Lymphoma
; 62(6): 1441-1449, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33467957
4.
MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.
Bioorg Med Chem Lett
; 20(12): 3561-4, 2010 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20529685
5.
Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.
Bioorg Med Chem Lett
; 20(12): 3557-60, 2010 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20529684
6.
Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.
Bioorg Med Chem Lett
; 20(2): 576-80, 2010 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20005097
7.
Phase I study of azacitidine following donor lymphocyte infusion for relapsed acute myeloid leukemia post allogeneic stem cell transplantation.
Leuk Res
; 49: 1-6, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27505705
8.
A study of high-dose lenalidomide induction and low-dose lenalidomide maintenance therapy for patients with hypomethylating agent refractory myelodysplastic syndrome.
Leuk Lymphoma
; 57(11): 2535-40, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27122296
9.
Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.
J Med Chem
; 59(1): 313-27, 2016 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-26653735
10.
Discovery of potent, nonsystemic apical sodium-codependent bile acid transporter inhibitors (Part 1).
J Med Chem
; 48(18): 5837-52, 2005 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-16134950
11.
Discovery of potent, nonsystemic apical sodium-codependent bile acid transporter inhibitors (Part 2).
J Med Chem
; 48(18): 5853-68, 2005 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-16134951
12.
Targeting bone marrow lymphoid niches in acute lymphoblastic leukemia.
Leuk Res
; 39(12): 1437-42, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26467815
13.
A phase I study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia.
Leuk Lymphoma
; 57(3): 728-30, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26674111
14.
A novel class of apical sodium co-dependent bile acid transporter inhibitors: the 1,2-benzothiazepines.
Bioorg Med Chem Lett
; 13(21): 3727-30, 2003 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-14552767